- Home
- CCLD vs KRRO Comparison
CCLD vs KRRO Comparison
Compare CCLD & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCLD
- KRRO
- Stock Information
- Founded
- CCLD 1999
- KRRO 2014
- Country
- CCLD United States
- KRRO United States
- Employees
- CCLD N/A
- KRRO N/A
- Industry
- CCLD Computer Software: Prepackaged Software
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- CCLD Technology
- KRRO Health Care
- Exchange
- CCLD Nasdaq
- KRRO Nasdaq
- Market Cap
- CCLD 157.0M
- KRRO 147.4M
- IPO Year
- CCLD 2014
- KRRO 2019
- Fundamental
- Price
- CCLD $3.35
- KRRO $30.38
- Analyst Decision
- CCLD Buy
- KRRO Strong Buy
- Analyst Count
- CCLD 2
- KRRO 7
- Target Price
- CCLD $3.00
- KRRO $96.71
- AVG Volume (30 Days)
- CCLD 756.1K
- KRRO 237.4K
- Earning Date
- CCLD 11-11-2025
- KRRO 11-11-2025
- Dividend Yield
- CCLD N/A
- KRRO N/A
- EPS Growth
- CCLD N/A
- KRRO N/A
- EPS
- CCLD 0.00
- KRRO N/A
- Revenue
- CCLD $111,794,000.00
- KRRO $6,281,000.00
- Revenue This Year
- CCLD $2.20
- KRRO $97.27
- Revenue Next Year
- CCLD $7.53
- KRRO N/A
- P/E Ratio
- CCLD $8,738.26
- KRRO N/A
- Revenue Growth
- CCLD 0.04
- KRRO N/A
- 52 Week Low
- CCLD $1.14
- KRRO $10.29
- 52 Week High
- CCLD $4.84
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- CCLD 52.44
- KRRO 62.40
- Support Level
- CCLD $3.35
- KRRO $20.20
- Resistance Level
- CCLD $3.98
- KRRO $37.03
- Average True Range (ATR)
- CCLD 0.23
- KRRO 3.66
- MACD
- CCLD -0.05
- KRRO -0.05
- Stochastic Oscillator
- CCLD 2.94
- KRRO 60.49
About CCLD CareCloud Inc.
CareCloud Inc delivers flexible, tech-enabled solutions for healthcare providers of all sizes and multi-specialties across the U.S. It is a healthcare technology company offering cloud-based solutions that simplify clinical, administrative, and financial workflows for medical practices of all sizes. Its comprehensive suite includes Electronic Health Records (EHRs), Practice Management, Revenue Cycle Management (RCM), Medical Billing, Telehealth, and Patient Experience solutions. The group helps practices increase efficiency, improve patient care, and drive sustainable growth-all while ensuring HIPAA compliance and seamless integration. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.